This financing will advance the preclinical development of their programs in autoimmunity and immuno-oncology. Cambridge, MA – Abcuro, a leading biotechnology company focused on immunology therapeutics, announced the completion of a $8M Series A financing round. Partners Innovation Fund, Kaitai … Read More